Friday, November 29, 2019

Exclusive | Cipla leads race for Wockhardt#39;s business divisions

Exclusive | Cipla leads race for Wockhardt#39;s business divisions Wockhardt, wants to reduce its debt burden and is seeking a valuation between Rs 2,400-2,700 crore

from Moneycontrol Business News https://www.moneycontrol.com/news/business/exclusive-|-cipla-leads-race-for-wockhardt39s-business-divisions_13228461.html

No comments:

Post a Comment

Zaynich's blockbuster potential lifts Wockhardt's long-term outlook

Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years o...